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The Pressure Wire as a Crystal Ball*Jan J. Piek, MD, PHD, Tim P. van de Hoef, MDD espite technical reﬁnements in intracoro-nary diagnostic techniques over the past 2decades, it was not until recently that the
monarchy of fractional ﬂow reserve (FFR), the cur-
rent clinical standard for invasive diagnosis of func-
tional coronary stenosis severity (1), was challenged
by a technique that takes advantage of contemporary
technology. The instantaneous wave-free ratio (iFR)
equals the resting distal coronary pressure–to–aortic
pressure ratio during a restricted part of cardiac dias-
tole: the wave-free period (2). The introduction of iFR
led to a revival of clinical coronary physiology,
resulting in numerous reports comparing iFR with
FFR and prompting a vivid debate on its appropriate-
ness for coronary stenosis evaluation. Although ﬁnal
judgment is awaited, with 2 ongoing randomized
clinical trials comparing FFR- and iFR-guided re-
vascularization (NCT02053038; NCT02166736), retro-
spective analyses and registries have endorsed the
usefulness of iFR to the utter surprise of many
investigators.
Despite its long-standing position as clinical stan-
dard, several challenging clinical scenarios remain
unresolved by FFR. Among others (3–6) is the physi-
ological assessment of serial coronary stenoses and
diffuse coronary artery disease. For serial stenoses,*Editorials published in JACC: Cardiovascular Interventions reﬂect the
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consequences of both stenoses together. However, it
does not allow identiﬁcation of the hemodynamic
severity of the stenoses individually, at least in a
clinically applicable manner, not even with a hyper-
emic pressure wire pullback (7,8). This is because
calculation of FFR requires maximal trans-stenotic
ﬂow, which is hampered by the additional resistance
induced by a secondary stenosis. In serial stenoses,
maximal transstenotic ﬂow through the proximal
stenosis is hampered by distal disease and vice versa
(7,8). The individual hemodynamic signiﬁcance of
serial stenoses cannot be assessed by FFR in clinical
practice because the extent of such interplay between
stenoses is not appreciable from pressure measure-
ments prior to revascularization alone. Moreover, the
physiological gain of revascularization of the individ-
ual stenosis cannot be estimated by FFR because the
change in transstenotic ﬂow after revascularization of
either stenosis is unpredictable. Whereas stenoses
of $50% diameter start limiting ﬂow in hyperemic
conditions and therefore cause stenosis interplay in
cases of serial stenoses, ﬂow in resting conditions
remains unaltered up to >85% diameter reduction
(9,10). Hence, although even mild secondary stenoses
may interfere with objective FFR measurement, ste-
nosis interplay is less likely to occur during resting
conditions (9,10). It is therefore conceivable that iFR
provides a more favorable tool for serial stenosis
assessment than FFR. Moreover, prediction of revas-
cularization success of individual stenoses may be
possible with iFR because resting ﬂow likely does not
materially change after revascularization.
Pure diffuse disease is even more challenging
for pressure wire assessment, where the gradual
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1398entrance and exit of the diseased segment limit pres-
sure losses resulting from ﬂow acceleration and sepa-
ration (3,11). This leads to small pressure gradients,
although ﬂow impairment may be substantial. A pres-
sure wire pullback may reveal diffuse disease as a
gradual loss of perfusion pressure across the vessel,
but FFR may not be fully representative of ﬂow
impairment, which partly explains the frequent
disagreement between FFR and ﬂow-based assess-
ment of coronary disease (5,6). Because these charac-
teristics are similar in resting and hyperemic
conditions, the advantage of resting conditions over
hyperemia (i.e., iFR over FFR) in pure diffuse disease
seems to be restricted to a nontrivial alleviation of the
need for intravenous hyperemic stimuli, limiting pa-
tient burden as well as improving laboratory logistics,
in particular in case repeated measurements are
needed.SEE PAGE 1386In this issue of JACC: Cardiovascular Interventions,
Nijjer et al. (12) show proof-of-concept of a pressure
wire pullback during resting conditions using the iFR
technology and demonstrate its potential for predic-
tion of physiological revascularization success. Using
repeated motorized pressure wire pullbacks pre- and
post-intervention, the authors show that pre-
intervention iFR gradients across serial stenosis and
concomitant diffuse disease allow prediction of post-
revascularization physiological gain in iFR within an
error of 2  1% and a small mean difference between
the predicted and observed post-revascularization
iFR (0.016  0.004). The authors expand their ob-
servations to potential future applications; a manual
pressure wire pullback with angiographic coregistra-
tion technology that allows physiological intensity of
coronary artery disease to be displayed, potentially
simplifying interpretation of pullback data and,
hence, clinical decision making. They ﬁnally observe
that the physiological length of the stenosis, deter-
mined by the motorized pressure wire pullback,
is substantially shorter than angiographic stenosis
length, hypothesizing potential beneﬁts of a phy-
siological approach to estimate the required stent
length.
It should be pointed out that the presented data
were obtained with a motorized pullback of a pressure
wire, analyzed ofﬂine for virtual revascularization
and physiological lesion length assessment. Obvi-
ously, such an approach is limited: practically by the
requisite of a motorized pressure wire pullback and
theoretically by a potential bias in the analyses for
virtual revascularization results. Hence, the clinical
applicability of iFR pullback is subject to conﬁrmationwith online acquisition and virtual revascularization
once the technology is clinically available. Addition-
ally, the authors did not speciﬁcally validate the use
of iFR to identify the hemodynamic severity of the
individual stenosis, for example, by sequential alle-
viation of serial stenoses (8). Although theoretically
conceivable and strongly suggested by the noted
successful post-revascularization iFR prediction in
the presence of residual and diffuse disease, the
robustness of iFR for this purpose should be subject to
further study. Nonetheless, in extrapolating the
ﬁndings in the present study to current clinical prac-
tice, performing multiple iFR measurements across a
coronary artery with serial stenoses should allow
identiﬁcation of physiological disease severity of
each coronary segment and even an estimation of
the expected physiological gain already with the
currently available iFR armamentarium. A live iFR
pullback with iFR gradients would further simplify its
assessment once available, and coregistration with
angiography to produce a physiological map of the
interrogated vessel is an intriguing use of contem-
porary technology and a potential game changer once
the technology is validated.
In contrast, the assessment of physiological lesion
length using iFR pullback is questionable. Pressure
loss along a stenosis geographically begins beyond
the entrance of the stenosis and extends beyond its
exit due to the concept of pressure recovery (11,13),
where the extent of both varies with the radius and
geometry of the stenosis, rheological factors, and
the magnitude of transstenotic ﬂow (3,11,13). As a
result, the measured pressure loss, and thus physi-
ological length, will be distributed asymmetrically
across the angiographic stenosis, starting within
and ending beyond the diseased segment (13).
The variability of this phenomenon likely hampers
appropriate stent length estimation, risking in-
sufﬁcient coverage of the diseased segment and
potentially resulting in an increased risk of stent
failure due to excess stent-edge plaque burden (14).
Although an appealing hypothesis, the validity and
robustness of this physiological approach to esti-
mate required stent length urges caution and thor-
ough validation.
Notwithstanding the preliminary status of the
ﬁndings, the present report from Nijjer et al. (12) is of
high interest and outweighs the ongoing iFR-FFR
debate, where ﬁnal judgment is eagerly awaited.
Right now, we need to acknowledge that serial ste-
noses and diffuse disease remain a clinical obstacle
not addressed by contemporary standards, and,
although clinical application of online iFR pullback
and virtual revascularization needs conﬁrmation,
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1399Nijjer et al. (12) provide a compelling argument that
iFR could provide us with a long-awaited tool to get a
glimpse of the future in diagnosis and percutaneous
treatment of serial stenosis and diffuse coronary ar-
tery disease.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Jan J. Piek, Academic Medical Center, AMC Heartcenter,
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